Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
38 hedge funds and large institutions have $15.3M invested in Albireo Pharma Inc in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 10 closing their positions.
17% less funds holding
Funds holding: 46 → 38 (-8)
61% less capital invested
Capital invested by funds: $39.1M → $15.3M (-$23.8M)
65% less call options, than puts
Call options by funds: $7K | Put options by funds: $20K
71% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 17
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$301K |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$196K |
| 3 |
PSUF
People's United Financial
Bridgeport,
Connecticut
|
+$16.8K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$13.4K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$9.27K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$848K |
| 2 |
OPPM
Opus Point Partners Management
New York
|
-$670K |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$583K |
| 4 |
BC
Broadfin Capital
New York
|
-$356K |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$284K |
ALBO Hedge Fund Activity: Q3 2015 in Review
38 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2015, worth a combined $15.3M — down 61% from $39.1M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ALBO and 2 opened new positions — a net loss of 8 holders — while 17 trimmed existing stakes and 5 added.
The largest buyer was Vanguard Group, adding an estimated $301K. The largest seller was AWM Investment Company, cutting an estimated $848K.
- 38 institutional investors held Albireo Pharma Inc (ALBO) as of Q3 2015, down from 46 in Q2 2015.
- Funds reported $15.3M of Albireo Pharma Inc stock for Q3 2015, down 61% quarter-over-quarter.
- 2 funds opened new Albireo Pharma Inc positions in Q3 2015 and 10 closed out, a net change of -8 holders.
- The largest Albireo Pharma Inc buyer in Q3 2015 was Vanguard Group, an estimated $301K added.
- The largest Albireo Pharma Inc seller in Q3 2015 was AWM Investment Company, an estimated $848K sold.
Based on aggregated 13F filings for Q3 2015.